Magali Philippeau

Title: Magali Philippeau: Innovator in G-Protein Coupled Receptor Research

Introduction

Magali Philippeau is a notable inventor based in Wemmel, Belgium. She has made significant contributions to the field of biochemistry, particularly in the study of G-protein coupled receptors (GPCRs). Her innovative work has led to the development of a patent that holds promise for various applications in diagnostics and therapeutic agents.

Latest Patents

Magali Philippeau holds a patent titled "Natural ligand of G protein coupled receptor RCC356 and uses thereof." This invention identifies isovaleric acid as a natural ligand of the RCC356 GPCR. The patent encompasses the use of the interaction between RCC356 polypeptides and isovaleric acid as a basis for screening assays aimed at identifying agents that modulate the activity of the RCC356 receptor. Additionally, it includes diagnostic assays and kits designed for performing these screening tests.

Career Highlights

Philippeau's career is marked by her dedication to advancing scientific knowledge in her field. She has successfully navigated the complexities of patent applications, ensuring that her innovations are protected and can be utilized for further research and development. Her work has implications for both academic research and practical applications in medicine.

Collaborations

Throughout her career, Magali has collaborated with esteemed colleagues, including Frédéric Sallman and Alex Veithen. These partnerships have enriched her research and contributed to the successful development of her patent.

Conclusion

Magali Philippeau is a pioneering inventor whose work on the RCC356 G-protein coupled receptor has opened new avenues for research and application. Her contributions to the field exemplify the importance of innovation in advancing scientific understanding and improving diagnostic methods.